The role of TGFβ in the pathogenesis of human tuberculosis

Clinical Immunology and Immunopathology

Volumn 87, Issue 2, 1998, Pages 107-114

  Toossi, Zahra ^a,c   Ellner, Jerrold J ^a,b  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^c Affairs Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DECORIN; LATENCY ASSOCIATED PEPTIDE; TRANSFORMING GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR INHIBITOR; UNCLASSIFIED DRUG;

CYTOKINE PRODUCTION; DISEASE ASSOCIATION; GENE OVEREXPRESSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; IMMUNOTHERAPY; INFECTION; MACROPHAGE ACTIVATION; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE ACTIVATION; TISSUE INJURY; TUBERCULOSIS;

EID: 0031860499     PISSN: 00901229     EISSN: None     Source Type: Journal    
DOI: 10.1006/clin.1998.4528     Document Type: Review

References (81)

1. Snider D. E., Raviglione M., Kochi A. Global burden of tuberculosis. Tuberculosis Pathogenesis, Protection, and Control. 1994;ASM Press, Materials Park. p. 3-11.
2. Ellner J. J. The human response in tuberculosis. J. Infect. Dis. 176:1997;1351-1359.
3. Wahl S. M. Transforming growth factor beta (TGFβ) in inflammation: a cause and a cure. J. Clin. Immunol. 12:1992;61-68.
4. Assoian R. K., Fleurdelys B. E., Stevenson H. C., Miller P. J., Madtes D. K., Raine E. W., Ross R., Sporn M. B. Expression and secretion of type B transforming growth factor by activated human macrophages. Proc. Natl. Acad. Sci. USA. 84:1987;6020-6025.
5. Scotto L., Vaduva P. I., Wager R. E., Assoian R. K. Type B1 transforming growth factor gene expression. J. Biol. Chem. 265:1990;2203-2206.
6. Roberts A. B., Sporn M. B. Differential expression of the TGFβ isoforms in embryogenesis suggests specific roles in developing and adult tissues. Mol. Reprod. Dev. 32:1992;91-93.
7. Kim S. J., Angel P., Lafyatis R., Hattori K., Kim K. Y., Sporn M. B., Karin M., Roberts A. B. Autoinduction of transforming growth factor B1 is mediated by the AP-1 complex. Mol. Cell. Biol. 10:1990;1492-1495.
8. Toossi Z., Hirsch C. S., Hamilton B. D., Knuth C. K., Friedlander M. A., Rich E. A. Decreased production of transforming growth factor β1 (TGFβ1) in human alveolar macrophages. J. Immunol. 156:1996;3461-3468.
9. Danielpour D., Kim K. Y., Winokur T. S., Sporn M. B. Differential regulation of the expression of transforming growth factorβs 1 and 2 by retinoic acid, epidermal growth factor, and dexamethasone in NRK-49F and A5449 cells. J. Cell. Phys. 148:1991;235-238.
10. Salbert G., Fanjul A., Piedrafita F. J., Lu X. P., Kim S. J., Pfahl M. Retinoic acid receptors and retinoid X receptorα down-regulate the transforming growth factorβ promoter by antagonizing AP-1 activity. Mol. Endo. 7:1993;1347-1352.
11. Wakefield L. M., Smith D. M., Flanders K. C., Sporn M. B. Latent transforming growth factorβ from human platelets. J. Biol. Chem. 263:1988;7646-7649.
12. Miyazono K., Heldin C. H. Role for carbohydrate structures in TGF-B 1 latency. Nature. 338:1989;158-160.
13. Pilatte Y., Bignon J., Lambre C. R. Lysosomal and cytosolic sialidases in rabbit alveolar macrophages; demonstration of increased lysosomal activity afterin vivo. Biochem. Biophys Acta. 923:1987;150-155.
14. Dubois C. M., Laprise M. H., Blanchette F., Gentry L. E., Leduc R. Processing of transforming growth factor beta 1 precursor by human furin convertase. J. Biol. Chem. 270:1995;10618-10624.
15. Ruscetti F., Mikovits J., Ranchalis J., Purchio T., Twardzik D. Gamma-interferon induced fresh human monocytes active latent transforming growth factorβ Ann. NY Acad. Sci. 593:1990;276-292.
16. Flaumenhaft R., Kojima S., Abe M., Rifkin D. B. Activation of latent transforming growth factorβ Adv. Pharmacol. 24:1993;51-76.
17. Espevik T., Figari I. S., Shalaby M. R., Lackides G. A., Lewis G. D., Shepard H. M., Palladino M. A. Jr. Inhibition of cytokine production by cyclosporin A and transforming growth factorB. J. Exp. Med. 166:1987;571-577.
18. Ruegemer J. J., Ho S. N., Augustine J. A., Abraham R. T. Regulatory effects of TGF β on IL-2 and IL-4 dependent T-cell cycle progression. J. Immunol. 144:1990;1767-1773.
19. Fargeas C., Wu C. Y., Makajima T., Cox D., Nutman T., Delespesse G. Differential effect of transforming growth factor β on the synthesis of TH1α and TH2-like lymphokines by human T lymphocytes. Eur. J. Immunol. 122:1992;2173-2180.
20. Ahuja S. S., Paliogianni F., Yamada H., Balow J. E., Boumpas D. T. Effect of transforming growth factorβ on early and late activation events in human T cells. J. Immunol. 150:1993;3109-3119.
21. Oberhammer F. A., Pavelka M., Sharma S., Tienfenbacher R., Purchio A. F., Bursch W., Schulte-Hermann R. Induction of apoptosis in cultured hepatacytes and in regressing liver by transforming growth factor β1. Proc. Natl. Acad. Sci. USA. 89:1992;5408-5413.
22. Mekori Y. A., Metcalfe D. D. Transforming growth factor β prevents stem cell factor mediated rescue of mast cells from apoptosis after IL-3 deprivation. J. Immunol. 153:1994;2194-2204.
23. Selvakumaran M., Lin H. K., Miyashita T., Wang H. G., Krajewski S., Reed J. C., Hoffman B., Liebermann D. Immediate early up-regulation of bax expression by p53 but not TGFB1: a paradigm for distinct apoptotic pathways. Oncogene. 9:1994;1791-1799.
24. Czarniecki C. W., Chiu H. H., Wong G. H. W., Mccabe S. M., Palladino M. A. Transforming growth factorβ1 modulates the expression of class II histocompatibility antigens on human cells. J. Immunol. 140:1988;4217-4224.
25. Bogdan C., Paik J., Vodovotz Y., Nathan C. Contrasting mechanisms for suppression of macrophage cytokine release by transforming growth factorβ and interleukin-10. J. Biol. Chem. 267:1992;23301-23306.
26. Dubois C., Ruscetti F., Palaszynke E. W., Falk L. A., Oppenheim J. J., Keller J. R. Transforming growth factor β is a potent inhibitor of interleukin 1(IL-1) receptor expression: proposed mechanism of inhibition of IL-1 action. J. Exp. Med. 172:1990;737-744.
27. Turner M., Chantry D., Katsikis P., Berger A., Brennan G. A., Feldman M. Induction of IL-1 receptor antagonist protein by transforming growth factor β J. Immunol. 21:1991;1635-1642.
28. Ding A., Nathan C., Srimal S. Macrophage deactivating factor and TGFβ inhibit of macrophage nitrogen oxide synthesis by IFNγ J. Immunol. 145:1990;940-945.
29. Rook G. A. W., Taverne J., Leveton C., Steele J. The role of gamma interferon, vitamin D3 metabolites, and tumor necrosis factor in the pathogenesis of tuberculosis. Immunology. 67:1987;229-234.
30. Rich, E. A. Knuth, C. K. Hamilton, B. D. Toossi, Z. Mycobacterium tuberculosis, Tubercle.
31. Ding A., Nathan C., Srimal S. Macrophage deactivating factor and TGFβ inhibit of macrophage nitrogen oxide synthesis by IFNγ J. Immunol. 145:1990;940-945.
32. Border W. A., Noble N. A. Transforming growth factor β in tissue fibrosis. N. Engl. J. Med. 331:1994;1286-1290.
33. Sporn M. B., Roberts A. B., Wakefield L. M., Assoian R. K. Transforming growth factor β biological function and chemical structure. Science. 233:1986;532-535.
34. Kasahari V. M., Chen Y. Q., Su M. W., Ramirez F., Uitto J. Tumor necrosis factorα and interferonγ suppress the activation of human type I collagen gene expression by transforming growth factorβ1. J. Clin. Invest. 86:1990;1489-1494.
35. Wahl S. M., Allen J. B., Weeks B. S. Transforming growth factor β enhances integrin expression and type IV collagenase secretion in human monocytes. Proc. Natl. Acad. Sci. USA. 90:1993;4577-4581.
36. Wahl S. M., Hunt D. A., Wakefield L. M., McCartney-Francis N., Wahl L. M., Roberts A. B., Sporn M. B. Transforming growth factor type β induces monocyte chemotaxis and growth factor production. Proc. Natl. Acad. Sci. USA. 84:1987;5788-5793.
37. Zugmaier G., Paik S., Wilding G. Transforming growth factor β1 induces cachexia and systemic fibrosis without an antitumor effect in nude mice. Cancer Res. 51:1991;3590-3594.
38. Anscher M. S., Peters W. P., Reisenbichler H., Petros W. P., Jirtle R. L. Transforming growth factor β as a predictor of liver and lung fibrosis after autologous bone marrow transplantation for advanced breast cancer. N. Engl. J. Med. 328:1993;1592-1596.
39. Broekelmann T. J., Limper A. H., Colby T. V., McDonald J. A. Transforming growth factor β is present at sites of extracellular matrix gene expression in human pulmonary fibrosis. Proc. Natl. Acad. Sci. USA. 88:1991;6642-6647.
40. Khalil N., Whitman C., Zuo L., Danielpour D., Greenberg A. Regulation of alveolar macrophage transforming growth factor β secretion by corticosteroids in bleomycin-induced pulmonary inflammation in the rat. J. Clin. Invest. 192:1993;1812-1817.
41. Limper A. H., Colby T. V., Asakura S., DeRmee R. A. Immunohistochemical granulomas of pulmonary sarcoidosis. Am. J. Respir. Crit. Care. Med. 149:1994;197-202.
42. Khalil N., Bereznay O., Sporn M., Greenberg A. H. Macrophage production of transforming growth factor beta and fibroblast collagen synthesis in chronic pulmonary inflammation. J. Exp. Med. 170:1989;727-737.
43. Border W. A., Noble N. A., Yamamoto T., Harper J. R., Yamaguchi Y., Pierschbacher M. D., Ruoslahti E. Natural inhibitor of transforming growth factorβ protects against carring inexperimental kidney disease. Nature. 360:1992;361-364.
44. Toossi Z., Gogate P., Shiratsuchi H., Young T., Ellner J. J. Enhanced production of transforming growth factorβ (TGFβ) by blood monocytes from patients with active tuberculosis and presence of TGFβ in tuberculous granulomatous lung lesions. J. Immunol. 54:1995;465-473.
45. Wallis R. S., Fujiwara H., Ellner J. J. Direct stimulation of monocyte release of interleukin 1 by mycobacterial protein antigens. J. Immunol. 36:1996;193-196.
46. Valone S. E., Rich E. A., Wallis R. S., Ellner J. Expression of tumor necrosis factor αin vitromycobacterium bovis. Infect. Immun. 56:1988;3313.
47. Toossi Z., Lapurga J., Ondash R., Sedor J., Ellner J. J. Expression of functional IL-2 receptors by peripheral blood monocytes from patients with active pulmonary tuberculosis. J. Clin. Invest. 85:1990;1777-1783.
48. Wallis R. S., Paranjabe R., Phillips M. Identification by two dimensional gel electrophoresis of a 58 kD tumor necrosis factor-inducing protein of mycobacterium tuberculosis. Infect. Immun. 61:1993;627-630.
49. Wiker H. G., Harboe M., Nagai S., Bennedsen J. Quantitative and qualitative studies on the major extracellular antigen of mycobacterium tuberculosis H37Rv mycobacterium BCG 1-3. Am. Rev. Resspir. Dis. 141:1990;830-835.
50. Yuan Y., Lee R. E., Besra G. S., Belisle J. T., Barry C. E. Identification of a gene involved in the biosynthesis of cyclopropanated mycolic acids in Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. USA. 92:1995;6630-6634.
51. Abou-Zeid C., Ratliff T. L., Wiker H. G., Harboe M., Bennedsen J., Rook G. A. W. Characterization of fibronectinβ binding antigens released byMycobacterium tuberculosisMycobacterium bovis. Infect. Immun. 56:1988;3046-3051.
52. Aung H., Toossi Z., Wisnieski J. J., Culp L. A., Phillips N. B., Averill L. E., Daniel T. M., Ellner J. J. Induction of monocytes expression of tumor necrosis factor alpha by the 30 kDa alpha antigen ofMycobacterium tuberculosis. J. Clin. Invest. 98:1996;1261-1268.
53. Hirsch C. S., Yoneda T., Ellner J. J., Averill L. E., Toossi Z. Enhancement of intracellular growth ofM. tuberculosis. J. Infect. Dis. 170:1994;1229-1237.
54. Toossi Z., Young T. G., Averill L. E., Hamilton B. D., Shiratsuchi H., Ellner J. J. Induction of transforming growth factorβ (TGFβ) by purified protein derivative (PPD) ofMycobacterium tuberculosis. Infect. Immun. 63:1995;224-228.
55. Dahl K. E., Shiratsuchi H., Hamilton B. D., Ellner J. J., Toossi Z. Selective induction of TGFβ in human monocytes by lipoarabinomannan ofM. tuberculosis. Infect. Immun. 64:1996;399-405.
56. Hirsch C. S., Hussain R., Toossi Z., Ellner J. J. Cross-modulatory role for transforming growth factor b in tuberculosis; Suppression of antigen driven interferon g production. Proc. Natl. Acad. Sci. USA. 93:1996;3193-3198.
57. Toossi Z., Kleinhenz M. E., Ellner J. J. Defective interleukin-2 production and responsiveness in human pulmonary tuberculosis. J. Exp. Med. 163:1986;1162-1167.
58. Onwubalili J. K., Scott G. M., Robinson J. A. Deficient immune interferon production in tuberculosis. Clin. Exp. Immunol. 59:1985;405-411.
59. Vilcek J., Klion A., Henriksen-DeStefano D., Zemtsov A., Davidson D. M., Davidson M., Friedman-Kien A. Defective gamma-interferon production in peripheral blood leukocytes of patients with acute tuberculosis. J. Clin. Immunol. 6:1986;146-151.
60. Barnes P. F., Lu S., Abrams J. S., Wang E., Yamamura M., Modlin R. L. Cytokine production at the site of disease in human tuberculosis. Infect. Immun. 61:1993;3482-3489.
61. Lin Y., Zhang H., Gong J., Barnes P. F. Absence of a prominent TH2 cytokine response in human tuberculosis. Infect. Immun. 64:1996;1351-1356.
62. Ogawa T., Uchida H., Kusumoto Y., Mori Y., Yamamura Y., Hamada S. Increase in tumor necrosis factor alpha and interleukin-6 secreting cells in peripheral blood mononuclear cells from subjects infected withMycobacterium tuberculosis. Infect. Immun. 59:1991;3021-3025.
63. Fujiwara H., Kleinhenz M. E., Wallis R. S., Ellner J. J. Increased interleukin-1 production and monocyte suppressor cell activity associated with human tuberculosis. Am. Rev. Respir. Dis. 133:1986;73-77.
64. Hirsch C. S., Jerrold J. E., Blinkhorn R. In Vitro restoration of T cell responses in tuberculosis and augmentation of monocyte effector function againstMycobacterium tuberculosis. Proc. Natl. Acad. Sci. USA. 94:1997;3926-3931.
65. Hirsch C. S., Toossi Z., Hussain R., Ellner J. J. Suppression of T-cell responses by TGFβ in tuberculosis. J. Invest. Med. 43:1995;365A.
66. Hirsch C. S., Toossi Z., Whalen C., Wallis R. S., Rich E. A., Ellner J. J. Co-pathogenesis of tuberculosis and HIV-1 infection. July, 1997;NIHNIAID. p. 157-160.
67. Barnes P. F., Fong F.-J., Brennan P. J., Twomey P. E., Mazmuder A., Modlin R. L. Local Production of TNFα and IFNγ in tuberculous pleuritis. J. Immunol. 45:1990;149-154.
68. Solis-Herruzo J. A., Brenner D. A., Chojkier M. Tumor necrosis factor a inhibits collagen gene transcpiption and collagen synthesis in cultured human fibroblasts. J. Biol. Chem. 263:1988;5841-5845.
69. Rook G. A. W., Bloom B. R. Mechanisms of pathogenesis in tuberculosis. Bloom B. Tuberculosis Pathogenesis, Protection, and Control. 1994;3-11 ASM Press, Materials Park.
70. Shwander S. K., Sada E., Torres M., Escobedo D., Sierra J. G., Alt S., Rich E. A. T lymphocytic and immature macrophage alveolitis in active pulmonary tuberculosis. J. Infect. Dis. 173:1996;1267-1272.
71. McCarthy-Francis N. L., Wahl S. M. Transforming growth factor b: a matter of life or death. J. Leuk. Biol. 55:1994;401-409.
72. Barrel A., Barrel-Neto M., Yong C. E., Brownell C. E., Twardzik D. R., Reed S. G. Transforming growth factor b as a virulence mechanism for Leishmania braziliensis. Proc. Natl. Acad. Sci. USA. 90:1993;3442-3447.
73. Silva J. S., Twardzik D. R., Reed S. Regulation ofTrypanosoma cruziin vitroin vivo. J. Exp. Med. 174:1991;539-545.
74. Williams M. E., Caspar P., Oswald I., Sharma H. K., Pankewycz O., Sher A., James S. L. Vaccination routes that fail to elicit protective imunity againstSchistosoma mansoni. J. Immunol. 154:1997;4693-4700.
75. Barral-Neto M., Barral A., Brodskyn C., Carvalho E. M. Cytotoxicity in human mucosal and ncutaneous leishmaniasis. Parasite Immunol. 17:1995;21-28.
76. King C. L., Mahanty S., Kumaraswami V., Abrams J. S., Regunthan J., Jayaraman K., Ottesen E. A., Nutman T. B. Cytokine controlof parasite-specific anergy in human lymphatic filariasis. J. Clin. Invest. 92:1993;1667-1673.
77. Zhang M., Gong J., Iyer D., Jones B. E., Modlin R. L., Barnes P. F. T-Cell cytokine responses in persons with tuberculosis and human immunodeficiency virus infection. J. Clin. Invest. 94:1994;2435-2440.
78. Lotz M., Seth P. TGF beta and HIV. Annu. NY Acad. Sci. 685:1993;501-511.
79. Maltman J., Pargnell I. B., Graham G. J. Specificity and reciprocity in the interactions between TGFβ and macrophage inflammatory protein-1α J. Immunol. 156:1996;1566-1571.
80. Yamaguchi Y., Mann D. M., Ruoslahti. Negative regulation of transforming growth factorβ by the proteoglycan decorin. Nature. 346:1990;281-283.
81. Bottinger E. P., Factor V. M., Tsang M. L. S. The recombinant proregion of transforming growth factor beta1 (latency associated peptide)inhibits activetransforming growth factor beta1 in transgenic mice. Proc. Natl. Acad. Sci. USA. 93:1992;5877-5882.